Cargando…
Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) among healthcare providers prior to the vaccine era in an integrated midwestern healthcare system
We performed severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antinucleocapsid IgG testing on 5,557 healthcare providers and found a seroprevalence of 3.9%. African Americans were more likely to test positive than Whites, and HCWs with household exposure and those working on COVID-19 cohort...
Autores principales: | Saade, Elie A., Zhang, Xiaochun, Noguez, Jaime H, Stempak, Lisa M., Tisch, Daniel, Schmotzer, Christine, Salata, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614926/ https://www.ncbi.nlm.nih.gov/pubmed/36310795 http://dx.doi.org/10.1017/ash.2022.29 |
Ejemplares similares
-
SARS-CoV-2 Seroprevalence Among First Responders in Northeastern Ohio, 2020
por: Zhang, Xiaochun, et al.
Publicado: (2022) -
SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays
por: Meyers, Jamie, et al.
Publicado: (2022) -
Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust
por: Grant, Joseph J., et al.
Publicado: (2020) -
Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure
por: Hunter, Benton R., et al.
Publicado: (2020) -
Impact of COVID-19 on dermatologic surgery: experience of a Midwestern academic practice
por: Hamel, Remi, et al.
Publicado: (2021)